166 related articles for article (PubMed ID: 10506130)
1. Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation.
Tintut Y; Parhami F; Le V; Karsenty G; Demer LL
J Biol Chem; 1999 Oct; 274(41):28875-9. PubMed ID: 10506130
[TBL] [Abstract][Full Text] [Related]
2. E3 ubiquitin ligase Smurf1 mediates core-binding factor alpha1/Runx2 degradation and plays a specific role in osteoblast differentiation.
Zhao M; Qiao M; Oyajobi BO; Mundy GR; Chen D
J Biol Chem; 2003 Jul; 278(30):27939-44. PubMed ID: 12738770
[TBL] [Abstract][Full Text] [Related]
3. The ubiquitin-proteasome system and cellular proliferation and regulation in osteoblastic cells.
Murray EJ; Bentley GV; Grisanti MS; Murray SS
Exp Cell Res; 1998 Aug; 242(2):460-9. PubMed ID: 9683533
[TBL] [Abstract][Full Text] [Related]
4. 3',5'-Cyclic adenosine monophosphate activation in osteoblastic cells: effects on parathyroid hormone-1 receptors and osteoblastic differentiation in vitro.
Koh AJ; Beecher CA; Rosol TJ; McCauley LK
Endocrinology; 1999 Jul; 140(7):3154-62. PubMed ID: 10385409
[TBL] [Abstract][Full Text] [Related]
5. Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells.
Shui C; Spelsberg TC; Riggs BL; Khosla S
J Bone Miner Res; 2003 Feb; 18(2):213-21. PubMed ID: 12568398
[TBL] [Abstract][Full Text] [Related]
6. Transient suppression of core-binding factor alpha 1 expression by basic fibroblast growth factor in rat osteoblast-like osteosarcoma ROS17/2.8 cells.
Tsuji K; Noda M
J Bone Miner Metab; 2001; 19(4):213-9. PubMed ID: 11448013
[TBL] [Abstract][Full Text] [Related]
7. Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism.
Bellido T; Ali AA; Plotkin LI; Fu Q; Gubrij I; Roberson PK; Weinstein RS; O'Brien CA; Manolagas SC; Jilka RL
J Biol Chem; 2003 Dec; 278(50):50259-72. PubMed ID: 14523023
[TBL] [Abstract][Full Text] [Related]
8. Identification of potential modifiers of Runx2/Cbfa1 activity in C2C12 cells in response to bone morphogenetic protein-7.
Gu K; Zhang L; Jin T; Rutherford RB
Cells Tissues Organs; 2004; 176(1-3):28-40. PubMed ID: 14745233
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone enhances In vitro vascular calcification by promoting osteoblastic differentiation of vascular smooth muscle cells.
Mori K; Shioi A; Jono S; Nishizawa Y; Morii H
Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2112-8. PubMed ID: 10479652
[TBL] [Abstract][Full Text] [Related]
10. Genistein stimulates osteoblastic differentiation via p38 MAPK-Cbfa1 pathway in bone marrow culture.
Liao QC; Xiao ZS; Qin YF; Zhou HH
Acta Pharmacol Sin; 2007 Oct; 28(10):1597-602. PubMed ID: 17883946
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.
Nakao Y; Koike T; Ohta Y; Manaka T; Imai Y; Takaoka K
Bone; 2009 May; 44(5):872-7. PubMed ID: 19442611
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of Cbfa1/Runx2 and osteocalcin gene expression by vitamin-D3, dexamethasone, and local growth factors in primary human osteoblasts.
Viereck V; Siggelkow H; Tauber S; Raddatz D; Schutze N; Hüfner M
J Cell Biochem; 2002; 86(2):348-56. PubMed ID: 12112004
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway.
Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM
Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720
[TBL] [Abstract][Full Text] [Related]
14. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells.
Xiao ZS; Hinson TK; Quarles LD
J Cell Biochem; 1999 Sep; 74(4):596-605. PubMed ID: 10440929
[TBL] [Abstract][Full Text] [Related]
15. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T
Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
[TBL] [Abstract][Full Text] [Related]
16. Degradation of the inducible cAMP early repressor (ICER) by the ubiquitin-proteasome pathway.
Folco EJ; Koren G
Biochem J; 1997 Nov; 328 ( Pt 1)(Pt 1):37-43. PubMed ID: 9359831
[TBL] [Abstract][Full Text] [Related]
17. Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha.
Gilbert L; He X; Farmer P; Rubin J; Drissi H; van Wijnen AJ; Lian JB; Stein GS; Nanes MS
J Biol Chem; 2002 Jan; 277(4):2695-701. PubMed ID: 11723115
[TBL] [Abstract][Full Text] [Related]
18. Expression of the PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells.
Tsuji K; Ito Y; Noda M
Bone; 1998 Feb; 22(2):87-92. PubMed ID: 9477230
[TBL] [Abstract][Full Text] [Related]
19. The promyelotic leukemia zinc finger promotes osteoblastic differentiation of human mesenchymal stem cells as an upstream regulator of CBFA1.
Ikeda R; Yoshida K; Tsukahara S; Sakamoto Y; Tanaka H; Furukawa K; Inoue I
J Biol Chem; 2005 Mar; 280(9):8523-30. PubMed ID: 15623533
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid hormone bone anabolic action requires Cbfa1/Runx2-dependent signaling.
Krishnan V; Moore TL; Ma YL; Helvering LM; Frolik CA; Valasek KM; Ducy P; Geiser AG
Mol Endocrinol; 2003 Mar; 17(3):423-35. PubMed ID: 12554794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
